Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets (Unaudited)

v2.4.0.8
Balance Sheets (Unaudited) (USD $)
Jun. 30, 2013
Sep. 30, 2012
Balance Sheets    
Cash $ 6,048,595 $ 2,632,413
Prepaid expenses 212,005 218,242
Total Current Assets 6,260,600 2,850,655
EQUIPMENT, net 36,019 43,111
OTHER ASSETS    
Patent costs, net 565,259 623,654
TOTAL ASSETS 6,861,878 3,517,420
Accounts payable and accrued expenses 211,680 300,462
Notes payable 42,400 22,037
Derivative liabilities    768,696
Total Current Liabilities 254,080 1,091,195
TOTAL LIABILITIES 254,080 1,091,195
Preferred stock, Series B; 6,000,000 shares authorized, $0.0001 par value, 500,000 and 5,583,336 shares issued and outstanding, respectively 50 558
Common stock; 180,000,000 shares authorized, $0.0001 par value, 19,677,792 and 15,752,896 shares issued and outstanding, respectively 1,968 1,575
Additional paid-in capital 38,985,217 30,966,379
Stock subscription receivable    (11,891)
Accumulated deficit (21,628,748) (21,628,748)
Deficit accumulated during the development stage (10,750,689) (6,901,648)
Total Stockholders' Equity 6,607,798 2,426,225
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 6,861,878 $ 3,517,420